Search results for: Precision Medicine
Filter search results
The Spanish Medicines Market Today
9 February 2011
…medicines whose retail price is less than €3.12. Expected savings from these cuts are €169m. In June 2010, new rebates were announced affecting only patented medicines reimbursed under the NHS….
Routine Funding in the UK NHS of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure
18 December 2017
…to innovative medicines across the European Union (EU). Since then the scope of authorisation via the centralised procedure has been broadened and made mandatory for orphan and oncology medicines. We…
Rare Disease Day 2022
28 February 2022
…Treatments for many rare conditions include the use of medicines; these medicines are referred to as orphan medicines. New innovative treatments are continually being developed, but there are a number…
OHE Lunchtime Seminar: Personalised Medicine: Is it an oil-rush or oil-spill?
16 January 2020
…touted as more efficient in testing new medicines. If accepted, this will change the whole process of regulating new medicines. The seminar will also discuss how personalised medicine threatens to…
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
31 March 2015
…are continually being made, information gaps remain. One such gap is the ability to monitor the use of medicines according to what the medicine has been used for (the ‘indication’)…
One Europe, one assessment? Unpacking the European Joint Clinical Assessment
28 May 2026
…national level, that has already been submitted at the EU level. Abbreviations: AIFA, Italian Medicines Agency; DMC, Danish Medicines Council; G-BA, Federal Joint Committee; HAS, French National Authority for Health; HTAR, Regulation (EU) 2021/2282 on…
Key Considerations for Early Access Schemes for Single-Administration (One-Time) Therapies
1 June 2021
…key considerations for how they may need to be adapted for single-administration therapies. What is the process for approval and access to medicines? Regulators recommend the authorisation of a medicine…
Just Released: Health and the Use of Medicines in Wales
3 November 2011
…their medicines allocations, although the reasons remain unclear. At the same time, however, Wales lags behind England in the uptake of new primary and secondary care medicines that have received…
Comparing Prescription Medicines Prices in the UK to Prices in Other Countries
23 October 2012
…its most recent PPRS Report to Parliament, the Department of Health included the 250 top-selling branded medicines used in primary care in England in 2011; medicines used predominantly in the…